MARUCCI, Gabriella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.164
EU - Europa 9.107
AS - Asia 6.734
SA - Sud America 835
Continente sconosciuto - Info sul continente non disponibili 577
AF - Africa 255
OC - Oceania 19
Totale 36.691
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.575
CN - Cina 2.735
SG - Singapore 1.960
RU - Federazione Russa 1.850
PL - Polonia 1.548
IT - Italia 1.514
DE - Germania 1.133
BR - Brasile 680
GB - Regno Unito 630
FR - Francia 567
HK - Hong Kong 543
UA - Ucraina 508
SE - Svezia 503
VN - Vietnam 501
CA - Canada 471
FI - Finlandia 351
TR - Turchia 242
KR - Corea 212
ZA - Sudafrica 171
IE - Irlanda 127
IN - India 122
JP - Giappone 100
BE - Belgio 81
NL - Olanda 72
EU - Europa 71
MX - Messico 70
AR - Argentina 67
BD - Bangladesh 45
CZ - Repubblica Ceca 41
ES - Italia 39
IR - Iran 38
PK - Pakistan 34
IQ - Iraq 30
EC - Ecuador 27
RO - Romania 23
AT - Austria 22
AE - Emirati Arabi Uniti 18
ID - Indonesia 18
TW - Taiwan 18
CH - Svizzera 15
KE - Kenya 15
AU - Australia 14
CO - Colombia 14
EG - Egitto 14
MA - Marocco 14
LT - Lituania 13
RS - Serbia 13
JO - Giordania 12
PE - Perù 12
SA - Arabia Saudita 12
VE - Venezuela 12
IL - Israele 11
PY - Paraguay 11
TN - Tunisia 11
UZ - Uzbekistan 11
AZ - Azerbaigian 10
HN - Honduras 10
JM - Giamaica 8
PH - Filippine 8
CL - Cile 7
LB - Libano 7
MY - Malesia 7
AM - Armenia 6
BG - Bulgaria 6
CI - Costa d'Avorio 6
HR - Croazia 6
OM - Oman 6
TH - Thailandia 6
AL - Albania 5
BY - Bielorussia 5
CR - Costa Rica 5
DZ - Algeria 5
GR - Grecia 5
NI - Nicaragua 5
DK - Danimarca 4
DO - Repubblica Dominicana 4
GE - Georgia 4
HU - Ungheria 4
NO - Norvegia 4
NP - Nepal 4
TT - Trinidad e Tobago 4
ET - Etiopia 3
GT - Guatemala 3
KW - Kuwait 3
KZ - Kazakistan 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
BB - Barbados 2
BO - Bolivia 2
KH - Cambogia 2
LV - Lettonia 2
LY - Libia 2
MD - Moldavia 2
MM - Myanmar 2
MU - Mauritius 2
PA - Panama 2
SC - Seychelles 2
Totale 36.159
Salva come PNG Salva come JPEG
Città #
Fairfield 1.493
Woodbridge 1.482
Ashburn 1.438
Dallas 1.327
Jacksonville 1.209
Warsaw 1.198
Singapore 1.005
Chandler 948
San Jose 857
Houston 816
Ann Arbor 709
Council Bluffs 705
Wilmington 689
Seattle 638
Cambridge 543
Boardman 512
Hong Kong 511
Beijing 457
Nanjing 409
Kraków 331
Toronto 297
Los Angeles 280
The Dalles 265
Camerino 246
Istanbul 191
Columbus 188
San Mateo 185
Seoul 183
New York 179
Düsseldorf 178
Helsinki 172
Tongling 167
Lawrence 163
Princeton 163
Ho Chi Minh City 162
Dearborn 158
Johannesburg 154
Lauterbourg 144
Ogden 137
Moscow 133
Santa Clara 129
London 128
Dublin 125
Nanchang 125
Buffalo 120
Lachine 117
Shanghai 112
Milan 107
Munich 105
Hanoi 101
Guangzhou 99
Chicago 91
Kunming 86
Tokyo 82
Brussels 75
San Diego 75
São Paulo 75
Shenyang 67
Tianjin 65
Frankfurt am Main 63
Jiaxing 62
Hebei 61
Orem 59
St Louis 54
Rome 48
Hangzhou 45
Edinburgh 44
Phoenix 44
Philadelphia 40
Wuhan 39
Denver 38
Centro 37
Venezia 36
Changsha 35
Chennai 35
Ningbo 35
Hefei 32
San Francisco 32
Dong Ket 31
Redwood City 31
Poplar 29
Stockholm 29
Turku 29
Brno 28
Brooklyn 28
Mexico City 28
Boston 27
Jinan 27
Manchester 27
Da Nang 26
Perugia 26
Trieste 26
Venice 26
Orange 25
Atlanta 24
Norwalk 24
Amsterdam 23
Falls Church 23
Hillsboro 23
Montreal 23
Totale 24.328
Salva come PNG Salva come JPEG
Nome #
1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: Structure-affinity/activity relationship at α1-adrenoceptor subtypes and at 5-HT1A receptors. 615
1,2,4-Benzothiadiazine derivatives as alpha1 and 5-HT1A receptor ligands 602
“1,3 Oxathiolane Muscarinic Ligands Modified at the Cationic Head”. 565
1,3-Dioxolane-based ligands as a novel class of alpha(1)-adrenoceptor antagonists 534
1,3-Dioxolane-based ligands as rigid analogues of Naftopidil: structure-affinity/activity relationships at alpha1 and 5-HT1A receptors. 531
A2AR agonists/A3R antagonists: design, synthesis, and biological evaluation of new ligands with dual activity 460
The Length and Flexibility of the 2-Substituent of 9-Ethyladenine Derivatives Modulate Affinity and Selectivity for the Human A2A Adenosine Receptor 412
Overview on Radiolabel-Free in Vitro Assays for GPCRs 407
Pharmacological characterization of the GPR17 receptor dual profile 402
GPR17 receptor modulators and their therapeutic implications: review of recent patents 393
The 1,2,4-Triazolo[4,3-a]pyrazin-3-one as a Versatile Scaffold for the Design of Potent Adenosine Human Receptor Antagonists. Structural Investigations to Target the A2A Receptor Subtype 390
The G Protein-Coupled Receptor GPR17: Overview and Update 375
2′,3′-O-Substituted ATP derivatives as potent antagonists of purinergic P2X3 receptors and potential analgesic agents 368
2’,3’-O-Substituted ATP derivatives as potent antagonists of purinergic P2X3 receptors and potential analgesic agents 360
Update on novel purinergic P2X3 and P2X2/3 receptor antagonists and their potential therapeutic applications 337
5HT2B receptor antagonists: a probe for spotting the pharmacophore 305
Adenine based acyclic-nucleotides as novel P2X3 receptor ligands 301
“Synthesis and α-Adrenoreceptor Blocking Properties of Phenoxybenzamine-Related (2-Chloroethyl)-(2,3-dihydrobenzo-[1,4] dioxin-2-ylmethyl)-(2-phenoxyethyl) Amines”. 293
Acetylshikonin isolated from Lithospermum erythrorhizon roots inhibits dihydrofolate reductase and hampers autochthonous mammary carcinogenesis in Δ16HER2 transgenic mice 293
Neuroprotective potential of adenosine A1 receptor partial agonists in experimental models of cerebral ischemia 288
Neuropeptide S Receptor: recent updates on non-peptide antagonist discovery 281
Synthesis and pharmacological profile of a series of 1-substituted-2-carbonyl derivatives of diphenidol: novel M4 muscarinic receptor antagonists 278
4-(4-Fluorobenzoyl)-1-[2-(4-iodo-2,5-dimethoxyphenyl)ethyl]piperidine and its derivatives: synthesis and affinity at 5-HT2A, 5-HT2B and 5-HT2c serotonin receptors 276
Levels of polychlorinated biphenyls in fish and shellfish from the Adriatic Sea 273
Medicinal Chemistry of P2X Receptors: Agonists and Orthosteric Antagonists 271
Simulation and Comparative Analysis of Different Binding Modes of Non-nucleoside Agonists at the A2A Adenosine Receptor 270
Synthesis and antimuscarinic activity of derivatives of 2-substituted-1,3-dioxolanes 269
Investigation on 2′,3′-O-Substituted ATP Derivatives and Analogs as Novel P2X3 Receptor Antagonists 265
Synthesis and alpha1-adrenoceptor antagonist activity of derivatives and isosters of the furan portion of (+)-cyclazosin 252
Antiproliferative Evaluation of Isofuranodiene on Breast and Prostate Cancer Cell Lines 250
Ex-vivo absorption study of lysine R-lipoate salt, a new pharmaceutical form of R-ALA 250
Antioxidant-conjugated 1,2,4-Triazolo[4,3-a]pyrazin-3-one Derivatives: Highly Potent and Selective Human A2A Adenosine Receptor Antagonists Possessing Protective Efficacy in Neuropathic Pain 247
Choline-Containing Phospholipids: Structure-Activity Relationships Versus Therapeutic Applications. 246
“New Pyridazinones: Synthesis and Correlation Between Structure and α-Blocking Activity”. 245
"[4-[[N-(3-Chlorophenyl)carbamoyl]-2-butynyl]-trimethylammonium (McN-A-343)-Related Compounds. Effect of the Butynyl Chain Inclusion into an Aromatic Unit of the Potency for Muscarinic Receptors 242
New substituted 9-propyladenine derivatives as A2Aadenosine receptor antagonists 241
Purinergic P2X receptors: Structural models and analysis of ligand-target interaction 240
Non-Nucleoside Agonists of the Adenosine Receptors: An Overview 240
14th Camerino-Noordwijkerhout Symposium - Ongoing Progress in Receptor Chemistry 239
Benzimidazole, benzoxazole and benzothiazole derivatives as 5HT(2B) receptor ligands. Synthesis and preliminary pharmacological evaluation 237
Innovative functional cAMP assay for studying G protein-coupled receptors: application to the pharmacological characterization of GPR17 235
“Third Joint Italian-German Purine Club Meeting - Purinergic Receptors: New Frontiers for Novel Therapies” 235
Chiral analogues of (+)-cyclazosin as potent α1B-adrenoceptor selective antagonist 232
(+)-Cyclazosin, a selective alpha1B-adrenoceptor antagonist: Functional evaluation in rat and rabbit tissues 230
A(2A) Adenosine receptor and its modulators: overview on a druggable GPCR and on structure-activity relationship analysis and binding requirements of agonists and antagonists 228
New sensible method to quantize the intestinal absorption of receptor ligands 228
(+)-Cyclazosin derivatives as α1-adrenoceptor antagonists 227
Structure-Activity Relatioships Among Novel Phenoxybenzamine-Related Beta-Chloroethylamines. 226
Molecular modeling studies on the human neuropeptide S receptor and its antagonists. 224
(2,2-Diphenyl-[1,3]oxathiolan-5-ylmethyl)-(3-phenyl-propyl)-amine: a Potent and Selective 5-HT1A Receptor Agonist 224
Synthesis and structure-activity relationships of novel arylpiperazines as potent antagonists of α1-adrenoceptor 224
Molecular modeling study on potent and selective adenosine A3 receptor agonists. 224
Antiviral properties of deazaadenine nucleoside derivatives 223
Evidence for the existence of a specific G protein-coupled receptor activated by guanosine 222
Deoxamuscaroneoxime Devatives as useful Muscarinic Aginist to Explore the Muscarinic Subsite: Demox, Amodulator of Orthosteric and Allosteric Site at Cardiac Muscarinic M2 Receptors. 221
A3 Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity 219
Determination of Muscarinic Agonist Potencies at M1 and M2 Muscarinic Receptors in a Modified Pithed rat Preparation 218
Analogues of Prazosin That Bear a Benextramine-Related Polyamine Backbone Exhibit Different Antagonism toward alpha1-Adrenoceptor Subtypes 218
Muscarinic subtype affinity and functional activity profile of 1-methyl-2-(2-methyl-1,3-dioxolan-4-yl)pyrrolidine and 1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine derivatives 217
Design, synthesis, and biological evaluation of prazosin-related derivatives as multipotent compounds 216
Simplified analogues of Ritanserin and their affinity at 5-HT2A, 5-HT2B and 5-HT2C serotonin receptors 216
Adenosine A(2A) receptor antagonists: new 8-substituted 9-ethyladenines as tools for in vivo rat models of Parkinson's disease 215
Comparison and optimization of transient transfection methods at human astrocytoma cell line 1321N1 215
Design, synthesis and muscarinic activity of deoxamuscarine-related derivatives 214
Novel human adenosine receptor antagonists based on the 7-amino-thiazolo[5,4-d]pyrimidine scaffold. Structural investigations at the 2-, 5- and 7-positions to enhance affinity and tune selectivity 214
Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 2. Role of the substituents on the phenyl ring and nitrogen atoms of caproctamine 214
Structure-activity relationships in 1,4-benzodioxan-related compounds. 7. Selectivity of 4-phenylchroman analogues for alpha(1)-adrenoreceptor subtypes 213
Different efficacy of adenosine and NECA derivatives at the human A3 adenosine receptor: Insight into the receptor activation switch 213
Adenosine receptor modeling: what does the A2A crystal structure tell us? 212
Synthesis and antagonistic activity at muscarinic receptor subtypes of some derivatives of diphenidol 211
Structure-activity relationships of methoctramine-related polyamines as muscular nicotinic receptor noncompetitive antagonists. 3. Effect of inserting the tetraamine backbone into a macrocyclic structure 210
Fragment optimization for GPCRs by molecular dynamics free energy calculations: Probing druggable subpockets of the A2A adenosine receptor binding site 210
Muscarinic subtypes profile modulation within a series of new antagonists, bridged bicyclic derivatives of 2,2-diphenyl-[1,3]-dioxolan-4-ylmethyl-dimethylamine 208
Frontal affinity chromatography-mass spectrometry useful for characterization of new ligands for GPR17 receptor. 207
Identification of alpha(1)-adrenoceptor subtypes involved in contraction of young CD rat epididymal vas deferens 205
16th Camerino-Noordwijkerhout Symposium - An Overview of Receptor Chemistry 205
Novel 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives as potent human adenosine A1 and A2A receptor antagonists. Evaluation of their protective effect against β-amyloid-induced neurotoxicity in SH-SY5Y cells 205
The importance of alkynyl chain presence for the activity of adenine nucleosides/nucleotides on purinergic receptors 204
“Dialkylaminoalkyl Esters of 2,2 Diphenyl-2-Alkylthioacetic Acids: A New Class of Potent and Functionally Selective Muscarinic Antagonists”. 204
“N,N-diethylaminoethanol and N-methyl-4-piperidinol Esters of 2,2-diphenyl-2-Ethylthioacetic Acid as Potent and Selective Muscarinic Antagonist”. 202
Innovative functional cAMP assay: application to the pharmacological characterization of GPR17 201
“Synthesis and Pharmacological Evaluation of Enantiomerically Pure 4-Deoxy-4-Fluoro-Muscarines”. 201
Synthesis and pharmacological characterization of enantiomerically pure muscarinic agonists: difluoromuscarines 200
Synthesis and α1-antagonist activity of derivatives of 4-chloro-5-{4-[2-(2-methoxyphenoxy)-ethyl]-1-piperazinyl}-3(2H)-pyridazinone 200
Molecular modulation of muscarinic antagonists. Synthesis and affinity profile of 2,2-diphenyl-2-ethylthio-acetic acid esters designed to probe the binding site cavity. 197
Evaluation of adenine as scaffold for the development of novel P2X3 receptor antagonists 197
Synthesis and pharmacological characterization of chiral pyrrolidinylfuran derivatives: The discovery of new functionally selective muscarinic agonists 196
Human adenosine A3 receptor as selective target of new 2-aralkynyl-N6-methyl-MECA derivatives 195
“Pharmacological Characterization of Muscarinic Receptor Subtypes in Rabbit Isolated Tissue Preparations” 193
Alpha(2)-adrenoreceptors profile modulation and high antinociceptive activity of (S)-(-)-2-[1-(biphenyl-2-yloxy)ethyl]-4,5-dihydro-1H-imidazole 192
Synthesis, affinity profile, and functional activity of muscarinic antagonists with a 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine structure 191
“Synthesis and α1-Antagonist Activity of New Prazosin-and Benextramine-Related Tetraamine Disulfides”. 191
“Synthesis and Pharmacological Activity of Some New Pyridazinones”. 190
Molecular modulation of muscarinic antagonists. Synthesis and pharmacological profile of 2,2-diphenyl-2-ethylthioacetic and 3,3-diphenyl-3-ethylthiopropionic acid derivatives characterized by a dipeptide spacer. 190
Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at α1 and 5-HT1A receptors 190
Searching for cyclazosin analogues as alfa1B-adrenoceptor antagonists 189
Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease 189
A2A Adenosine Receptor Antagonists: Are Triazolotriazine and Purine Scaffolds Interchangeable? 189
Highly chiral muscarinic ligands: The discovery of (2S,2 ' R,3 ' S,5 ' R)-1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine 3-sulfoxide methyl iodide, a potent, functionally selective, M-2 partial agonist 188
Functional cAMP assay optimization at CHO cells expressing A2A adenosine receptors and stably transfected with firefly luciferase biosensor 186
Totale 25.896
Salva come PNG Salva come JPEG
Categoria #
all - tutte 140.853
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 140.853
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.788 0 478 39 103 99 65 100 154 145 228 147 230
2022/20232.322 257 120 84 384 260 312 13 146 385 121 170 70
2023/20241.769 252 102 112 59 71 115 86 103 198 70 63 538
2024/20255.716 203 146 485 264 159 340 639 1.449 429 403 399 800
2025/20269.332 534 593 1.706 1.137 959 660 1.363 583 546 520 447 284
2026/2027821 586 235 0 0 0 0 0 0 0 0 0 0
Totale 36.691